Citizens Against Government Waste America's #1 Taxpayer Watchdog

As the May 18 deadline for negotiating a modernized North American Free Trade Agreement (NAFTA) looms, negotiators should consider closely how intellectual property (IP) rights will be treated between the countries involved.

The President has already made some good policy decisions and has offered other proposals that will help to lower drug costs.

You may recall a March 5, WasteWatcher blog, “New FDA Report on BPA: It is Still Safe,” which discussed a pre-peer review draft study released by the National Toxicology Program (NTP) on bisphenol A (BPA), a compound used to produce plastic products and epoxy resins used in food and beverage can linings.  The study, two-years in length and the largest ever conducted on BPA, took place at the Food and Drug Administration’s (FDA) National Center for Toxicological Research (NCTR).

This prudent decision will send a strong message to other state legislatures across the country not to pursue similar legislation.

The Patient Protection and Affordable Care Act, or Obamacare, is bringing many changes in the healthcare space and few are as subtly transformative as the rapid increase in cross-industry consolidation.  A record breaking 115 mergers and acquisitions among hospitals and health systems occurred in 2017, an increase of 13 percent from 2016.

On February 15, 2018, 18 Democratic members of Congress sent a letter to Health and Human Services (HHS) Secretary Alex Azar, asking him to use his authority under 28 U.S.C.

On April 11, 2018, Virginia legislators will return to Richmond for a special session in which they will aim to finish work on the Commonwealth’s budget.  At center stage, yet again, is the issue of Medicaid expansion, still unresolved eight years after Obamacare became law.